86 related articles for article (PubMed ID: 18032895)
1. Clinical characteristics and psychopathological profile of patients with vulvodynia: an observational and descriptive study.
Tribó MJ; Andión O; Ros S; Gilaberte M; Gallardo F; Toll A; Ferrán M; Bulbena A; Pujol RM; Baños JE
Dermatology; 2008; 216(1):24-30. PubMed ID: 18032895
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial and sexual functioning in women with vulvodynia and chronic pelvic pain. A comparative evaluation.
Reed BD; Haefner HK; Punch MR; Roth RS; Gorenflo DW; Gillespie BW
J Reprod Med; 2000 Aug; 45(8):624-32. PubMed ID: 10986680
[TBL] [Abstract][Full Text] [Related]
3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
4. Vulvar pain. Psychological profiles and treatment responses.
Schmidt S; Bauer A; Greif C; Merker A; Elsner P; Strauss B
J Reprod Med; 2001 Apr; 46(4):377-84. PubMed ID: 11354840
[TBL] [Abstract][Full Text] [Related]
5. Open-label trial of lamotrigine focusing on efficacy in vulvodynia.
Meltzer-Brody SE; Zolnoun D; Steege JF; Rinaldi KL; Leserman J
J Reprod Med; 2009 Mar; 54(3):171-8. PubMed ID: 19370903
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective study.
D'Erme AM; Zanieri F; Campolmi E; Santosuosso U; Betti S; Agnoletti AF; Cossidente A; Lotti T
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):246-9. PubMed ID: 22963277
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
[TBL] [Abstract][Full Text] [Related]
8. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.
King M; Sibbald B; Ward E; Bower P; Lloyd M; Gabbay M; Byford S
Health Technol Assess; 2000; 4(19):1-83. PubMed ID: 11086269
[TBL] [Abstract][Full Text] [Related]
10. High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain.
Romão AP; Gorayeb R; Romão GS; Poli-Neto OB; dos Reis FJ; Rosa-e-Silva JC; Nogueira AA
Int J Clin Pract; 2009 May; 63(5):707-11. PubMed ID: 19392920
[TBL] [Abstract][Full Text] [Related]
11. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
12. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
[TBL] [Abstract][Full Text] [Related]
13. Burning mouth syndrome and vulvodynia coexisting in the same patient: a case report.
Gaitonde P; Rostron J; Longman L; Field EA
Dent Update; 2002 Mar; 29(2):75-6. PubMed ID: 11928344
[TBL] [Abstract][Full Text] [Related]
14. Psychosomatic aspects of vulvodynia. Comparison with the chronic pelvic pain syndrome.
Bodden-Heidrich R; Küppers V; Beckmann MW; Ozörnek MH; Rechenberger I; Bender HG
J Reprod Med; 1999 May; 44(5):411-6. PubMed ID: 10360252
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of vulvodynia patients. A prospective study of 300 patients.
Sadownik LA
J Reprod Med; 2000 Aug; 45(8):679-84. PubMed ID: 10986689
[TBL] [Abstract][Full Text] [Related]
16. Trait anxiety and defensive functioning in relation to antidepressant treatment outcome.
Sukul YR; Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA
Psychopathology; 2009; 42(6):387-93. PubMed ID: 19776669
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of depression in treatment-seeking women with vulvodynia.
Masheb RM; Wang E; Lozano C; Kerns RD
J Obstet Gynaecol; 2005 Nov; 25(8):786-91. PubMed ID: 16368586
[TBL] [Abstract][Full Text] [Related]
18. Vulvodynia: a psychophysiological profile based on electromyographic assessment.
Jantos M
Appl Psychophysiol Biofeedback; 2008 Mar; 33(1):29-38. PubMed ID: 18214669
[TBL] [Abstract][Full Text] [Related]
19. Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia.
Masheb RM; Lozano-Blanco C; Kohorn EI; Minkin MJ; Kerns RD
J Sex Marital Ther; 2004; 30(5):315-24. PubMed ID: 15672599
[TBL] [Abstract][Full Text] [Related]
20. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.
Park HY; Lee BJ; Kim JH; Bae JN; Hahm BJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):318-23. PubMed ID: 22142651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
